These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29897253)
1. Drug combination studies of curcumin and genistein against rhodesain of Ettari R; Previti S; Maiorana S; Allegra A; Schirmeister T; Grasso S; Zappalà M Nat Prod Res; 2019 Dec; 33(24):3577-3581. PubMed ID: 29897253 [TBL] [Abstract][Full Text] [Related]
2. Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Di Chio C; Previti S; De Luca F; Bogacz M; Zimmer C; Wagner A; Schirmeister T; Zappalà M; Ettari R Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430948 [TBL] [Abstract][Full Text] [Related]
3. Drug combination studies of PS-1 and quercetin against rhodesain of Di Chio C; Previti S; De Luca F; Allegra A; Zappalà M; Ettari R Nat Prod Res; 2022 Aug; 36(16):4282-4286. PubMed ID: 34533390 [TBL] [Abstract][Full Text] [Related]
4. Comments on "Drug combination studies of curcumin and genistein against rhodesain of Steverding D Nat Prod Res; 2020 Mar; 34(6):751-753. PubMed ID: 30251878 [No Abstract] [Full Text] [Related]
5. Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of Ettari R; Previti S; Di Chio C; Maiorana S; Allegra A; Schirmeister T; Zappalà M ACS Med Chem Lett; 2020 May; 11(5):806-810. PubMed ID: 32435388 [TBL] [Abstract][Full Text] [Related]
6. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain. McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866 [TBL] [Abstract][Full Text] [Related]
7. Improved trypanocidal activities of cathepsin L inhibitors. Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956 [TBL] [Abstract][Full Text] [Related]
9. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense. Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806 [TBL] [Abstract][Full Text] [Related]
10. Activity of extracts and naphthoquinones from Kigelia pinnata against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Moideen SV; Houghton PJ; Rock P; Croft SL; Aboagye-Nyame F Planta Med; 1999 Aug; 65(6):536-40. PubMed ID: 10483374 [TBL] [Abstract][Full Text] [Related]
11. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents. Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888 [TBL] [Abstract][Full Text] [Related]
13. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense. Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206 [TBL] [Abstract][Full Text] [Related]
14. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB. Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405 [TBL] [Abstract][Full Text] [Related]
15. On the Reversible and Irreversible Inhibition of Rhodesain by Curcumin. Steverding D Molecules; 2019 Dec; 25(1):. PubMed ID: 31905815 [TBL] [Abstract][Full Text] [Related]
16. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines. Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078 [TBL] [Abstract][Full Text] [Related]
17. Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors. Giroud M; Dietzel U; Anselm L; Banner D; Kuglstatter A; Benz J; Blanc JB; Gaufreteau D; Liu H; Lin X; Stich A; Kuhn B; Schuler F; Kaiser M; Brun R; Schirmeister T; Kisker C; Diederich F; Haap W J Med Chem; 2018 Apr; 61(8):3350-3369. PubMed ID: 29590750 [TBL] [Abstract][Full Text] [Related]
18. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs). Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614 [TBL] [Abstract][Full Text] [Related]
19. Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis. Ettari R; Previti S; Maiorana S; Amendola G; Wagner A; Cosconati S; Schirmeister T; Hellmich UA; Zappalà M J Med Chem; 2019 Dec; 62(23):10617-10629. PubMed ID: 31714776 [TBL] [Abstract][Full Text] [Related]